Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Efficient pre-treatment device for culturing human umbilical cord mesenchymal stem cells and related application thereof

A pretreatment device and stem cell technology, applied in the direction of biomass pretreatment, biomass post-treatment, bioreactor/fermenter for specific purposes, etc. cumbersome and other problems, to achieve the effect of promoting the use, low cost and stable technology

Active Publication Date: 2017-12-15
上海莱威生物科技有限公司
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

When the human umbilical cord tissue is pretreated, the human umbilical cord tissue needs to be pretreated in different processing equipment or containers, and the human umbilical cord tissue is easily polluted by microorganisms such as bacteria and viruses in the air in this large space transfer overshoot Therefore, the current culture of human umbilical cord mesenchymal stem cells under this open pretreatment method is cumbersome, inefficient, consumes a lot of manpower and material resources, and has a high talent rate, so it cannot be popularized and applied on a large scale.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Efficient pre-treatment device for culturing human umbilical cord mesenchymal stem cells and related application thereof
  • Efficient pre-treatment device for culturing human umbilical cord mesenchymal stem cells and related application thereof
  • Efficient pre-treatment device for culturing human umbilical cord mesenchymal stem cells and related application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] Example 1 as figure 1 As shown, this embodiment provides a high-efficiency pretreatment device for human umbilical cord mesenchymal stem cells, which specifically includes: a reversible upper cover 100, the upper cover 100 is provided with knife grooves 101, and the knife grooves 101 are composed of at least two groups Different depths and mutual grid-like sub-slots are composed; the housing 200 hingedly connected with the upper cover 100; the cutting assembly 300 located at the opening of the housing 200, the cutting assembly 300 is arranged in cooperation with the upper cover 100 to wash The final umbilical cord segment is cut into small pieces of tissue with the same size; the cutting assembly 300 is composed of a grid-shaped blade 301 and an elastic sealing ring 302, and the grid-shaped blade 301 is composed of at least two groups of sub-blades arranged in an upper and lower staggered arrangement, And the grid-shaped blade 301 is set corresponding to the knife groov...

Embodiment 2

[0076] Example 2 This example provides a method for pretreatment of human umbilical cord mesenchymal stem cells using the high-efficiency pretreatment device of Example 1, including the following steps:

[0077] Step 1) Acquisition of Human Umbilical Cord Tissue

[0078] To obtain human umbilical cord tissue from newborns, try to use newborn umbilical cords delivered by cesarean section to avoid contamination; put the umbilical cord segment in iced saline, keep it at a low temperature of about 4 degrees, and quickly bring it back to the cell laboratory. In the safety cabinet, the umbilical cord segment was fully washed with iced saline to remove blood and impurities. After the umbilical artery and umbilical vein were removed, the umbilical cord segment was repeatedly folded into 5-8 layers of 5 cm × 5 cm tissue blocks. Put the tissue block into the cutting assembly 300, select the cutting specifications of the grid-shaped blade 301 and the knife groove 101 according to the nee...

Embodiment 3

[0083] Example 3 This example provides a method for culturing human umbilical cord mesenchymal stem cells pretreated in Example 2 above, including the following steps:

[0084] Step 1) Culture medium preparation

[0085] Prepare DMEM / F12 medium containing 20% ​​fetal bovine serum and 1% penicillin-streptomycin, and DMEM / F12 medium containing 10% fetal bovine serum and 1% penicillin-streptomycin; in order to improve human umbilical cord mesenchymal For the adherent survival rate of stem cells, on the first day of primary culture, subculture and recovery, culture with DMEM / F12 medium containing 20% ​​fetal bovine serum and 1% penicillin-streptomycin; at other times, culture with 10% fetal Bovine serum, 1% penicillin and streptomycin in DMEM / F12 medium for cultivation;

[0086] Step 2) Two-dimensional culture

[0087] The purer human umbilical cord mesenchymal stem cells pretreated in Example 2 were taken, and the purer human umbilical cord mesenchymal stem cells were resuspend...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an efficient pre-treatment device for culturing human umbilical cord mesenchymal stem cells and a related application thereof. The efficient pre-treatment device comprises a turnover upper cover, a cutting assembly, a digestion assembly and a cleaning centrifugal part, wherein a cutter groove is formed in the upper cover; the cutting assembly located at an opening of a shell is composed of latticed blades and an elastic seal ring and the latticed blades and the cutter groove are correspondingly arranged; the digestion assembly is located in the middle of the shell; and the cleaning centrifugal part is located on the lower portion of the shell. The invention also provides a cell pre-treatment and culture method based on the efficient pre-treatment device. The method comprises the following six steps: human umbilical cord cutting and separating; enzymic digestion; centrifugal purification; culture medium preparation; two-dimensional culture; and subculture. The cell culture method based on the efficient pre-treatment device disclosed by the invention is stable in technology and good in repeatability, avoids the problems of low cell activity and poor yield, improves the cell activity and yield greatly, simplifies the operating process, and is flexible and convenient to use.

Description

technical field [0001] The invention belongs to the technical field of human cell culture, in particular to a high-efficiency pretreatment device for culturing human umbilical cord mesenchymal stem cells and its corresponding application Background technique [0002] Mesenchymal stem cells are a kind of very characteristic adult stem cells. These cells have the potential to differentiate into a variety of mature cells including: adipocytes, chondrocytes, bone cells, tenocytes and muscle cells. These properties, as well as their developmental plasticity, have drawn considerable attention from the scientific community as they could be exploited in regenerative medicine research. In vitro, mesenchymal stem cells isolated from umbilical cord Wharton's jelly can differentiate into neurons and glial cells after being induced by nerve-directed induction medium, Shh and FGF8. Mesenchymal stem cells can also be differentiated into adipocytes and osteoblasts. In addition, in the my...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12M1/40C12M1/00C12N5/0775
CPCC12M21/18C12M45/02C12N5/0665C12N2509/00
Inventor 王晓冰
Owner 上海莱威生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products